NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
RVP
Retractable Technologies, Inc.
There isn't enough reported data to score RVP yet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RVP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
RVP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
RVP PE Valuation
RVP has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
RVP Forward outlook
There aren't enough analyst estimates for RVP to show an outlook.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over RVP on earnings quality, reporting a profit while its opponent remains loss making.
RVP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.13 | +$0.15 |
| Q1 2026 | -$0.22 | +$0.54 |
| Q4 2025 | -$0.43 | -$0.03 |
| Q3 2025 | -$0.20 | +$0.34 |
| Q2 2025 | -$0.28 | +$0.33 |
| Q1 2025 | -$0.76 | -$0.50 |
| Q4 2024 | -$0.40 | -$0.16 |
| Q3 2024 | -$0.54 | -$0.17 |
RVP is still losing money, but far less than before: $0.13 per share over the past year, against $0.76 at its worst in early 2025.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over RVP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over RVP on profitability, with a higher operating margin.
RVP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.2M | -31% |
| Q1 2026 | $7.2M | -13% |
| Q4 2025 | $9.4M | +4% |
| Q3 2025 | $10.1M | -2.5% |
| Q2 2025 | $10.4M | +73% |
| Q1 2025 | $8.3M | +9.2% |
| Q4 2024 | $9.1M | -36% |
| Q3 2024 | $10.3M | +0.1% |
RVP's revenue has slid since its 2021 peak: $7M last quarter, down 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -71% | -22 points |
| Q1 2026 | -86% | -30 points |
| Q4 2025 | -82% | -2.1 points |
| Q3 2025 | -36% | +13 points |
| Q2 2025 | -49% | +47 points |
| Q1 2025 | -56% | -17 points |
| Q4 2024 | -80% | -60 points |
| Q3 2024 | -50% | -41 points |
RVP's operating margin was −71% last quarter, down 22 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over RVP on cash generation, producing positive trailing cash flow while its opponent burns cash.
RVP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | +$2.3M |
| Q1 2026 | -$1.4M | +$187.9K |
| Q4 2025 | -$596.5K | +$806.3K |
| Q3 2025 | -$1.3M | +$5.2M |
| Q2 2025 | -$4.1M | -$1.2M |
| Q1 2025 | -$1.6M | +$686.6K |
| Q4 2024 | -$1.4M | -181% |
| Q3 2024 | -$6.5M | -185% |
RVP has burned cash in most quarters: −$5M over the past year, against −$14M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over RVP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
RVP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | -0.8% | -232K shares |
| 5 years | -13% | -4.4M shares |
| Available history | -8.4% | -2.7M shares |
RVP has 30M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | $4.8M |
| Q3 2022 | — |
| Q2 2022 | $270,453 |
| Q1 2022 | $2.5M |
| Q4 2021 | $2.4M |
| Q3 2021 | $2.7M |
| Q2 2021 | $154,424 |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
RVP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -4.8x | Net Cash |
| Q3 2022 | -0.3x | Net Cash |
| Q2 2022 | -0.4x | Net Cash |
| Q1 2022 | -0.7x | Net Cash |
| Q4 2021 | -0.4x | Net Cash |
| Q3 2021 | -0.3x | Net Cash |
| Q2 2021 | -0.3x | Net Cash |
| Q1 2021 | -0.6x | Net Cash |
RVP has more cash than debt.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
RVP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 1.7 | Oversold |
RVP's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
RVP PE vs Healthcare Sector
| Metric | RVP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
RVP has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over RVP on trend strength, trading above more of its moving averages.
RVP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.61 | 8.2% below |
| 20 week MA | $0.66 | 15% below |
| 50 week MA | $0.69 | 19% below |
| 100 week MA | $0.73 | 23% below |
| 200 week MA | $0.96 | 42% below |
RVP is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over RVP on returns for 2026, with the stronger performance.
RVP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.47 | $11.3 | +669% |
| 2021 | $11.3 | $6.98 | -38% |
| 2022 | $6.98 | $1.74 | -75% |
| 2023 | $1.74 | $1.11 | -36% |
| 2024 | $1.11 | $0.68 | -39% |
| 2025 | $0.68 | $0.83 | +22% |
| 2026 YTD | $0.83 | $0.56 | -33% |
RVP's yearly returns have swung widely, from +669% in 2020 to −75% in 2022. It's down 33% so far in 2026.